Menold Daniel
Officer at CymaBay Therapeutics, Inc.
- Sold, on record
- $1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jan 16, 2024
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CymaBay Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice CymaBay Therapeutics, Inc.NoticeDec 15, 2023 2023
Filed to sell 21,497 shares ($473k)
Menold Daniel, Officer
10b5-1 planFiling
- 2 Form 4 sale CymaBay Therapeutics, Inc.RoutineJan 16, 2024 +32 days
Sold 10,000 shares at $23.58 ($236k)
Menold Daniel, Vice President, Finance
10b5-1 planSold 100% of holdings ($236k position)0 shares leftFollows a Form 144Filing
- 3 Form 144 notice CymaBay Therapeutics, Inc.NoticeJan 16, 2024 same day
Filed to sell 10,000 shares ($236k)
Menold Daniel, Officer
10b5-1 planFiling
- 4 Form 144 notice CymaBay Therapeutics, Inc.NoticeJan 26, 2024 +10 days
Filed to sell 20,000 shares ($461k)
Menold Daniel, Officer
No 10b5-1 plan1x usual sizeFiling
- 5 Form 144 notice CymaBay Therapeutics, Inc.NoticeJan 29, 2024 +3 days
Filed to sell 50,000 shares ($1.2M)
Menold Daniel, Officer
No 10b5-1 plan2.4x usual sizeFiling
- 6 Form 144 notice CymaBay Therapeutics, Inc.NoticeJan 30, 2024 +1 day
Filed to sell 25,000 shares ($594k)
Menold Daniel, Officer
No 10b5-1 plan1.2x usual sizeFiling
- 7 Form 144 notice CymaBay Therapeutics, Inc.NoticeFeb 1, 2024 +2 days
Filed to sell 25,000 shares ($600k)
Menold Daniel, Officer
No 10b5-1 plan1.2x usual sizeFiling
- 8 Form 144 notice CymaBay Therapeutics, Inc.NoticeFeb 15, 2024 +14 days
Filed to sell 10,000 shares ($322k)
Menold Daniel, Officer
10b5-1 plan0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Feb 15, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 10,000 | $322k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 25,000 | $600k | Notice | SEC | |
| Jan 30, 2024 | Jan 30, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 25,000 | $594k | Notice | SEC | |
| Jan 29, 2024 | Jan 29, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 50,000 | $1.2M | Notice | SEC | |
| Jan 26, 2024 | Jan 26, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 20,000 | $461k | Notice | SEC | |
| Jan 16, 2024 | Jan 16, 2024 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 10,000 | $236k | Notice | SEC | |
| Jan 16, 2024 | Jan 16, 2024 | CymaBay Therapeutics, Inc. | Vice President, Finance | Form 4 sale | 10,000 | $236k | 100.0% | Routine | SEC |
| Dec 15, 2023 | Dec 15, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 21,497 | $473k | Notice | SEC | |
| Dec 15, 2023 | Dec 15, 2023 | CymaBay Therapeutics, Inc. | Vice President, Finance | Form 4 sale | 21,497 | $473k | 100.0% | Routine | SEC |
| Nov 15, 2023 | Nov 15, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 17,500 | $304k | Notice | SEC | |
| Oct 16, 2023 | Oct 16, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 17,500 | $241k | Notice | SEC | |
| Sep 15, 2023 | Sep 15, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 16,545 | $279k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 15,500 | $186k | Notice | SEC | |
| Aug 9, 2023 | Aug 11, 2023 | CymaBay Therapeutics, Inc. | Vice President, Finance | Form 4 sale | 20,945 | $259k | 100.0% | Routine | SEC |
| Aug 9, 2023 | Aug 9, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 20,945 | $259k | Notice | SEC | |
| Aug 29, 2018 | Aug 31, 2018 | CymaBay Therapeutics, Inc. | Vice President, Finance | Form 4 sale | 5,000 | $65k | 100.0% | Unusual | SEC |